Brind.

Morgan Stanley, MSCI, Raymond James Financial, and Benzinga are involved in the process of receiving and issuing analyst ratings and research reports on company stocks.

3 reports, 3 independent Updated Oct 14
Gone quiet
Reports
3
Developments
5
Repetition
67%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 3 independent outlets

Morgan Stanley, MSCI, Raymond James Financial, and Benzinga are involved in the process of receiving and issuing analyst ratings and research reports on company stocks.

Who's involved

What this event is mainly about
Morgan StanleyMSCIRaymond James FinancialBenzinga

How it developed

Newest first. Tap a step to see who reported it.
  1. Morgan Stanley and Raymond James Financial issued conflicting analyst ratings (raise/downgrade) for V2X, Inc. on August 18, 2026.Sub-event
  2. Morgan Stanley raised price targets and ratings for Ultragenyx Pharmaceutical.Sub-event
  3. Morgan Stanley raised its price forecast for Palo Alto Networks, while Benzinga assigned a Momentum score to the company.Sub-event
  4. Jefferies Financial Group began coverage of MSCI stock, while Raymond James raised its target price and Morgan Stanley reaffirmed its rating.Sub-event
  5. Financial firms are issuing research reports and analyst ratings on company stock.1 source

Keep exploring

The entities involved

Related events

Coverage

Newest first; wire copies grouped